Infectious Disease

Home Infectious Disease
A surge in prescriptions for hydroxychloroquine/chloroquine was seen during the COVID-19 pandemic

Hydroxychloroquine Prescriptions Surge in U.S. During Pandemic

Increase in hydroxychloroquine/chloroquine fills seen during week of March 15 to 21, 2020
Body mass index is associated with tracheal intubation and/or death within seven days among individuals with diabetes hospitalized for COVID-19

BMI, Tracheal Intubation/Death Linked in Diabetes With COVID-19

In multivariable analyses with covariates, only BMI was positively linked to primary outcome
Despite adoption of enhanced safety measures

Radiation Oncology Clinic Visits Down Due to COVID-19

Patient volume decreased despite vast majority of practices adopting enhanced safety practices
A significant decline was seen in the monthly surgical case volume of acute type A aortic dissection in New York City after COVID-19

Significant Drop Seen in Type A Aortic Dissection After COVID-19

Monthly surgical case volume of aortic dissection declined 76.5 percent; volumes low in March, April
Health care workers in Italy who treated COVID-19 patients self-report substantial mental health symptoms

Italian Health Care Workers’ Mental Health Suffering During COVID-19

Symptoms of posttraumatic stress disorder, depression, anxiety, and insomnia all common

May 2020 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2020. This roundup includes the...
The first human trial of an antibody therapy to treat COVID-19 is underway

Human Trial of Antibody Therapy to Treat COVID-19 Underway

If drug proves safe and effective, it could be available for use by the fall
For patients with cancer and COVID-19

ASCO: Mortality High for Cancer Patients With COVID-19

Factors linked to 30-day mortality include age, male sex, smoking status, comorbidities, active cancer
For residents of California and Washington with COVID-19

Burden of Severe COVID-19 High in California, Washington State

Length of stay was 9.3 days for survivors; probability high for ICU admission, mortality
There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation

Five-Day Course of Remdesivir Beneficial in Severe COVID-19

No significant difference seen in five-, 10-day course for severe COVID-19 without mechanical ventilation